Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
Ticker SymbolINBS
Company nameIntelligent Bio Solutions Inc
IPO dateDec 23, 2020
CEOMr. Harry Simeonidis
Number of employees13
Security typeOrdinary Share
Fiscal year-endDec 23
Address135 W 41St St,
CityNEW YORK
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code10036
Phone16467905756
Websitehttps://ibs.inc/
Ticker SymbolINBS
IPO dateDec 23, 2020
CEOMr. Harry Simeonidis
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data